Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;12(10):1627-36; discussion 1636-7.
doi: 10.1007/s11605-008-0629-1. Epub 2008 Aug 13.

Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection

Affiliations
Free article

Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection

Roos E Pouw et al. J Gastrointest Surg. 2008 Oct.
Free article

Abstract

Background: Radiofrequency ablation is safe and effective for complete eradication of nondysplastic Barrett esophagus (BE). The aim was to report the combined results of two published and two ongoing studies on radiofrequency ablation of BE with early neoplasia, as presented at SSAT presidential plenary session DDW 2008.

Methods: Enrolled patients had BE < or = 12 cm with early neoplasia. Visible lesions were endoscopically resected. A balloon-based catheter was used for circumferential ablation and an endoscope-based catheter for focal ablation. Ablation was repeated every 2 months until the entire Barrett epithelium was endoscopically and histologically eradicated.

Results: Forty-four patients were included (35 men, median age 68 years, median BE 7 cm). Thirty-one patients first underwent endoscopic resection [early cancer (n = 16), high-grade dysplasia (n = 12), low-grade dysplasia (n = 3)]. Worst histology remaining after resection was high-grade (n = 32), low-grade (n = 10), or no (n = 2) dysplasia. After ablation, complete histological eradication of all dysplasia and intestinal metaplasia was achieved in 43 patients (98%). Complications following ablation were mucosal laceration at resection site (n = 3) and transient dysphagia (n = 4). After 21 months of follow-up (interquartile range 10-27), no dysplasia had recurred.

Conclusions: Radiofrequency ablation, with or without prior endoscopic resection for visible abnormalities, is effective and safe in eradicating BE and associated neoplasia.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Surg Endosc. 2006 Jan;20(1):125-30 - PubMed
    1. Endoscopy. 2008 May;40(5):359-69 - PubMed
    1. Gastrointest Endosc. 2007 Feb;65(2):185-95 - PubMed
    1. Gastroenterology. 1989 May;96(5 Pt 1):1249-56 - PubMed
    1. Gastroenterology. 2006 Nov;131(5):1392-9 - PubMed

Publication types